Gene · 3549
NIH grants2,031
NIH grants whose papers are about the gene, through NIH's grant-paper links.
221 to 240 of 2,031
Download this page as JSON| Grant | Title | IHH papers | Newest fiscal year |
|---|---|---|---|
| R01HL155104 | Type I IFN signaling during lung development in Down Syndrome | 1 | 2025 |
| R01HL160856 | Deciphering a Novel LncRNA-mediated Lipid Droplet Transport System in Human Heart | 1 | 2025 |
| R01NS116037 | Overcoming Resistance Mechanisms in Hedgehog and Myc-amplified Medulloblastoma | 1 | 2025 |
| R01NS121337 | Neuroprotection by a Secreted Component of the Cellular Stress Response | 1 | 2025 |
| R24OD010435 | Research Resources for Model Amphibians | 1 | 2025 |
| R35GM118063 | Cell signaling in development and regeneration | 1 | 2025 |
| R35GM118082 | Signal transduction in development and disease | 1 | 2025 |
| R35GM122530 | Lipid regulation of cellular signaling and protein-protein interactions | 1 | 2025 |
| R35HL145228 | A Mechanistic and Translational Research Program Linking Impaired Resolution, Defective Efferocytosis, and Clonal Hematopoiesis to the Formation of Clinically Dangerous Atherosclerotic Plaques | 1 | 2025 |
| R37AA018282 | The role of oxidative stress in alcohol-induced osteopenia | 1 | 2025 |
| R37CA237421 | Intratumoral Metabolic Crosstalk Promotes Therapeutic Resistance in Pancreatic Cancer | 1 | 2025 |
| R37CA245330 | Defining the Roles of Bone Marrow Adipocytes and FABP4/5 Signaling in Multiple Myeloma Drug Resistance | 1 | 2025 |
| R37HD091856 | Transcription Factor Control of Neuronal Diversity | 1 | 2025 |
| R50CA211506 | Preclinical Models for Cancer Therapeutic Development | 1 | 2025 |
| R90DE023056 | Dental Academic Research Training Program (DART) | 1 | 2025 |
| SC1GM144021 | TRPM7 induces tumorigenesis and stemness through Notch activation in glioma | 1 | 2025 |
| T15LM007088 | Research Training in Biomedical Informatics and Data Science at Oregon Health & Science University | 1 | 2025 |
| T32AI007051 | Immunologic Diseases and Basic Immunology | 1 | 2025 |
| T32AI007526 | Emerging and Tropical Infectious Diseases | 1 | 2025 |
| T32AR056950 | Musculoskeletal Research Training Program | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3549/grants?page=12